Foundayo (Orforglipron)

Foundayo (orforglipron) is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.

Limitations of Use: Concomitant use with another GLP-1 receptor agonist is not recommended.

Recommended Dosage:
Follow the Foundayo starting dosage and escalation described below to reduce the risk of gastrointestinal (GI) adverse reactions.

• The starting recommended dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.
• After at least 30 days on the 2.5 mg dosage, increase the dosage to 5.5 mg once daily.
• The dosage may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily) after at least 30 days on the current dosage, based on treatment response and tolerability.
• The maximum dosage of Foundayo is 17.2 mg once daily.

Take this medicine orally once daily, with or without food. Swallow tablets whole, without breaking, crushing, or chewing. Do not take more than one tablet per day.

If a dose is missed, instruct patients to take the dose as soon as possible. Patients should not double the next dose. If 7 or more consecutive doses are missed, restart dosage escalation at a lower dosage to reduce the risk of gastrointestinal side effects.

• As per some studies, treatment with Foundayo may increase the risk of thyroid C-cell tumors. It is unknown if this risk applies to humans. Do not use in patients with a personal or known family history of medullary thyroid carcinoma or MEN 2 syndrome.
• Acute pancreatitis may occur in patients using this medicine. Monitor for severe abdominal pain that may radiate to the back, with or without vomiting. Stop treatment promptly in case pancreatitis is suspected and get immediate medical evaluation and care.
• Treatment with this drug may cause life-threatening gastrointestinal side effects such as diarrhea, nausea, vomiting, and abdominal pain. These reactions may lead to dehydration. Patients should be monitored closely, especially during dose escalation, and advised to maintain adequate fluid intake during treatment.
• Serious vomiting, diarrhea, or dehydration from this treatment may cause acute kidney injury. Monitor kidney function in those at risk, especially those with existing kidney issues. Encourage adequate hydration and adjust or stop treatment if kidney function worsens significantly.
• When used with insulin or insulin secretagogues, this medicine may increase the risk of hypoglycemia. Monitor blood glucose levels regularly and consider dose adjustments of concomitant antidiabetic medications. Educate patients on recognizing symptoms such as sweating, dizziness, and confusion for early management.
• Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with similar medications. If symptoms such as swelling, rash, or difficulty breathing occur, discontinue Foundayo immediately and seek medical attention. Patients with prior hypersensitivity to similar drugs should use caution.
• Treatment with Foundayo may increase the risk of gallbladder-related events such as cholelithiasis or cholecystitis. Monitor patients for symptoms like upper abdominal pain, fever, or jaundice. Appropriate clinical evaluation and treatment should be initiated if gallbladder disease is suspected during therapy.
• There are limited findings on the use of Foundayo during pregnancy. It may pose risks to the fetus based on certain studies. Use only if the potential benefit justifies the risk. Consult a clinician before initiating or stopping therapy during pregnancy.
• It is not known whether this medicine is excreted in human milk. Because of the potential risk to the breastfed infant, a decision should be made whether to discontinue breastfeeding or stop the medicine, considering the importance of the treatment to the mother.

What documents are required to import FOUNDAYO to India?

FOUNDAYO (orforglipron) tablets may be imported by patients or government hospitals in the patients’ names only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is FOUNDAYO available in India?

FOUNDAYO (orforglipron tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Foundayo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Foundayo price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

FOUNDAYO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of FOUNDAYO (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Foundayo cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source FOUNDAYO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Foundayo®?

Orforglipron is the Generic Name for the trade name drug Foundayo®.

What is the Manufacturer’s Name of Foundayo®?

Foundayo® is manufactured by Eli Lilly and Company.

Is Foundayo® approved by the FDA?

Yes. Foundayo® is approved by the FDA. Date of first approval: April 1, 2026.

What strengths and dosage forms are available for Foundayo®?

Foundayo® is available as tablets: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg of orforglipron for oral administration.

What are the most common side effects of Foundayo® tablets?

The most commonly reported side effects of Foundayo are nausea, headache, constipation, diarrhea, abdominal distension, vomiting, abdominal pain, fatigue, eructation, flatulence, gastroesophageal reflux disease, dyspepsia, and hair loss.

What is the availability of Foundayo near Medanta Hospital in Gurgaon?

Patients receiving treatment near Medanta Hospital can buy Foundayo through a patient-specific import pathway. With a valid oncologist’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.

What is the availability of Foundayo in Bangalore?

Foundayo in Bangalore is not yet commercially marketed, but patients can still access it through regulated import provisions. Once prescribed by a treating clinician, the medicine is sourced internationally and supplied to the treating hospital.

Is Foundayo available at HCG Cancer Centre, Bangalore?

Foundayo may not be routinely stocked in India. However, it can be accessed through a Named Patient Program (NPP) with a valid prescription from an oncologist at the hospital. Indian Pharma Network (IPN) can help facilitate the import of Foundayo at HCG Cancer Centre, Bangalore.

What is the availability of Foundayo in Mumbai?

The patient can buy Foundayo in Mumbai via special access programs that allow the import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.

I want to buy Foundayo in Mumbai. How can I access it?

If you are looking to buy Foundayo in Mumbai, the first step is consultation with your oncologist. Once prescribed, the medicine can be sourced from global suppliers through a compliant import process and delivered to your treating hospital.

What is the availability of Foundayo in Chennai?

Patient access to Foundayo in Chennai is possible through special access programs such as Named Patient Programs (NPP), which allow the import of internationally approved medicines. The treatment is arranged and delivered directly to the hospital where the patient is receiving care, ensuring compliance with regulatory requirements.

I want to buy Foundayo in Chennai. How can I access it?

If you are looking to buy Foundayo in Chennai, the first step is to consult your oncologist. Upon prescription, the medicine can be sourced from global suppliers through a compliant import process under NPP and delivered to your treating hospital, such as Apollo Hospitals Chennai or Cancer Institute (WIA).

What is the availability of Foundayo in Hyderabad?

Foundayo is accessible in Hyderabad through special access programs like Named Patient Programs (NPP), which enable the legal import of medicines not widely available in India. The medication is delivered directly to the hospital where the patient is undergoing treatment.

I want to buy Foundayo in Hyderabad. How can I access it?

To access Foundayo in Hyderabad, patients should first consult their oncologist. Once prescribed, the medicine can be arranged through authorized channels under NPP guidelines and delivered to the treating hospital, such as Basavatarakam Indo-American Cancer Hospital.

I want to buy Foundayo in Bangalore. How can I access it?

Patients seeking access to Foundayo in Bangalore should consult their oncologist for evaluation and prescription. Following this, the medicine can be procured through compliant import channels and delivered to the treating hospital, such as HCG Cancer Centre Bangalore.

Can I buy Foundayo at major hospitals like Tata, HCG Cancer Centre, Apollo, or Fortis?

Foundayo can be accessed at leading hospitals such as Tata Memorial Centre, HCG Cancer Centre, Basavatarakam Indo-American Cancer Hospital, Cancer Institute (WIA), Apollo Hospitals, Fortis Healthcare, Max Healthcare, Rajiv Gandhi Cancer Institute & Research Centre, Manipal Hospitals, and Kokilaben Dhirubhai Ambani Hospital through the Named Patient Program (NPP) with a valid oncologist’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

How does Foundayo Import in India work?

Foundayo Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Foundayo supplier in India?

Indian Pharma Network is a trusted Foundayo supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Foundayo cost in India?

Foundayo is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Foundayo prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Foundayo cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Foundayo be available in SAARC countries?

Apart from Gulf countries, Foundayo can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Foundayo in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Foundayo online in India?

Yes, one can buy Foundayo in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Foundayo through legal channels.

Who is an authorized Foundayo importer in India?

Indian Pharma Network acts as the Foundayo importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

In which countries is Foundayo approved?

Foundayo (orforglipron) has been approved in the United States (FDA) and the United Arab Emirates (UAE) for use in adults with obesity or overweight with weight-related medical problems.

Can I buy Foundayo from Europe, the USA, or other countries?

As of now, Foundayo is approved and available in the United States (FDA) and the United Arab Emirates (UAE), but patients in India cannot directly purchase it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.

What are the storage conditions of Foundayo® tablets?

Store Foundayo at room temperature 20°C to 25° C (68°F to 77° F); excursions permitted between 15°C and 30°C (59°F and 86°F). This medicine is light-sensitive, so store the bottle away from light.